UNICA IRIS Institutional Research Information System

DEIDDA, MARTINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 194.140
NA - Nord America 9.348
AS - Asia 3.605
SA - Sud America 630
Continente sconosciuto - Info sul continente non disponibili 447
AF - Africa 100
OC - Oceania 31
Totale 208.301
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 192.138
US - Stati Uniti d'America 9.153
SG - Singapore 1.427
CN - Cina 1.170
SE - Svezia 505
BR - Brasile 484
UA - Ucraina 464
VN - Vietnam 376
FI - Finlandia 233
DE - Germania 206
GB - Regno Unito 205
FR - Francia 165
HK - Hong Kong 120
CA - Canada 100
IN - India 82
BD - Bangladesh 81
KR - Corea 61
AR - Argentina 50
MX - Messico 46
IQ - Iraq 43
NL - Olanda 37
JP - Giappone 35
ZA - Sudafrica 33
AT - Austria 27
AU - Australia 27
ES - Italia 27
RU - Federazione Russa 26
ID - Indonesia 25
TR - Turchia 24
PH - Filippine 23
PL - Polonia 21
BE - Belgio 20
CO - Colombia 20
PK - Pakistan 19
CL - Cile 18
EC - Ecuador 18
UZ - Uzbekistan 18
MA - Marocco 17
MY - Malesia 15
EG - Egitto 14
VE - Venezuela 12
IR - Iran 11
AZ - Azerbaigian 10
CU - Cuba 9
JM - Giamaica 9
PE - Perù 9
TN - Tunisia 9
JO - Giordania 8
PY - Paraguay 8
KE - Kenya 7
KZ - Kazakistan 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
PR - Porto Rico 6
RS - Serbia 6
AL - Albania 5
BG - Bulgaria 5
BO - Bolivia 5
HR - Croazia 5
IE - Irlanda 5
IL - Israele 5
OM - Oman 5
UY - Uruguay 5
CH - Svizzera 4
GT - Guatemala 4
KG - Kirghizistan 4
LT - Lituania 4
NZ - Nuova Zelanda 4
CR - Costa Rica 3
DZ - Algeria 3
GR - Grecia 3
HN - Honduras 3
MD - Moldavia 3
NG - Nigeria 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
TW - Taiwan 3
BH - Bahrain 2
BW - Botswana 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
KW - Kuwait 2
LV - Lettonia 2
MM - Myanmar 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CY - Cipro 1
Totale 207.838
Salva come PNG Salva come JPEG
Città #
Cagliari 172.605
Uta 19.040
Fairfield 909
Ashburn 752
Woodbridge 728
Singapore 672
Houston 517
Dallas 483
San Jose 463
Chandler 408
Wilmington 396
Ann Arbor 390
Seattle 349
Nyköping 343
Boardman 341
Cambridge 317
Beijing 253
Jacksonville 249
Dearborn 210
Council Bluffs 180
Los Angeles 149
Santa Clara 140
Helsinki 139
Hong Kong 110
Ho Chi Minh City 107
The Dalles 102
Nanjing 99
Boston 98
Lauterbourg 95
New York 94
Shanghai 72
Hanoi 67
Hefei 67
Dong Ket 64
Buffalo 58
Seoul 58
San Diego 56
Redwood City 50
São Paulo 49
London 41
Guangzhou 39
Shenyang 36
Toronto 36
Milan 35
Orem 33
Atlanta 32
Chicago 32
Nanchang 32
Phoenix 32
Tokyo 31
Munich 30
Tianjin 29
Frankfurt am Main 26
Hebei 26
Brooklyn 25
Columbus 24
Nuremberg 22
Changsha 20
Da Nang 20
Jiaxing 20
Mountain View 19
Rome 19
Chennai 18
Baghdad 17
Jinan 17
Manchester 17
Redondo Beach 17
Rio de Janeiro 17
Warsaw 17
Norwalk 16
Brussels 15
Montreal 15
Tashkent 15
Zhengzhou 15
Denver 14
Haiphong 14
Mexico City 14
Wuhan 14
Auburn Hills 13
San Francisco 13
Turku 13
Amsterdam 12
Kunming 12
Miami 12
Quartu Sant'elena 12
Vienna 12
Mumbai 11
Quito 11
Falls Church 10
Johannesburg 10
Kuala Lumpur 10
Medellín 10
Naples 10
Orange 10
Washington 10
Augusta 9
Belo Horizonte 9
Detroit 9
Hải Dương 9
Lappeenranta 9
Totale 202.426
Salva come PNG Salva come JPEG
Nome #
Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers 12.931
Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography 4.381
Metabolomic approach to profile functional and metabolic changes in heart failure 4.240
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 4.186
Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension 3.949
Endodontic infection and endothelial dysfunction are associated with different mechanisms in men and women 3.887
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance 3.571
Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease 3.544
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.479
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.422
Effects of metformin and exercise training, alone or in combination, on cardiac function in individuals with insulin resistance 3.355
Cardiovascular effects, body composition, quality of life and pain after a Zumba® fitness program in Italian overweight women 3.161
Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state 3.140
A new type of physical activity from an ancient tradition: the Sardinian folk dance "ballu sardu" 3.124
Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine 3.025
Metabolomics and heart failure: a new and promising scientific approach 3.000
Coronary Artery Disease 2.941
Altered transmural contractility in postmenopausal women affected by cardiac syndrome X 2.848
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.839
Modelling chemotherapy-induced cardiotoxicity by human pluripotent stem cells 2.763
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 2.754
Metabolomic approach to redox and nitrosative reactions in cardiovascular diseases 2.719
Metabolomics, a promising approach to translational research in cardiology 2.700
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 2.559
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 2.498
Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity 2.426
Effects of Metformin Treatment on Myocardial and Endothelial Function in Insulin Resistance Patients: A Metabolomic Study. 2.424
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.317
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 2.286
Women-specific predictors of cardiovascular disease risk - new paradigms 2.264
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.259
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 2.247
Inverted Takotsubo cardiomyopathy induced by dobutamine stress echocardiography with atypical presentation 2.201
Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus 2.181
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 2.180
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.170
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects 2.121
IGENDA protocol: gender differences in awareness, knowledge and perception of cardiovascular risk: an Italian multicenter study 2.113
Trastuzumab-based adjuvant chemotherapy for breast cancer: Early myocardial dysfunction detected by "speckle tracking" echocardiography (STE). 2.089
The need of a gender-corrected evidence based medicine 2.083
Could ADMA levels in young adults born preterm predict an early endothelial dysfunction? 2.027
Association of endodontic infection with detection of an initial lesion to the cardiovascular system 2.004
Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention 1.974
Metabolic pathways in heart failure correlate with impaired longitudinal global strain rate 1.949
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 1.937
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 1.892
Bridging the mortality gap: A new challenge in percutaneous coronary intervention for patients with cancer 1.876
Early right ventricular dysfunction in highly selected (totally free from cardiovascular risk factors and other comorbidities) human immunodeficiency virus patients: A pilot study with advanced echocardiography 1.836
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients 1.796
Gender differences in cardiology: is it time for new guidelines? 1.770
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 1.741
L’analisi metabolomica delle vie metaboliche nei pazienti affetti da scompenso cardiaco correla con lo strain rate longitudinale 1.713
Gender-specific aspects in primary and secondary prevention of cardiovascular disease 1.643
Subclinical contractility impairment in HIV-infected patients: Dependence on the class of antiretroviral drugs 1.586
Subclinical contractility impairment in HIV-infected patients varies according to class of antiretroviral drugs 1.577
Vascular damage-Coronary artery disease 1.563
Ankle-brachial index and its link to automated carotid ultrasound measurement of intima-media thickness variability in 500 Japanese coronary artery disease patients 1.549
Association of automated carotid IMT measurement and HbA1c in Japanese patients with coronary artery disease 1.528
Diastolic Function in Systemic Sclerosis Patients: A Neglected Issue? 1.523
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) 1.508
null 1.489
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.484
null 1.471
Early Ventricular Dysfunction in Type II Diabetes: Role of Metabolic Unbalance 1.426
Altered transmural contractility in women affected by cardiac X syndrome 1.416
Metabolomics: a new era in cardiology? 1.363
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry 1.354
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.329
Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects 1.314
Sex differences in congenital heart defects and genetically induced arrhythmias 1.306
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.288
Cardiotoxicity from anthracycline and cardioprotection in paediatric cancer patients 1.242
null 1.234
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 1.185
Looking for the gender equality 1.160
Relationship between high values of HOMA-IR and cardiovascular response to metformin 1.154
Novel insights in pathophysiology of antiblastic drugs-induced cardiotoxicity and cardioprotection 1.121
Different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 1.050
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin 998
Impact of COVID-19 on the cardiovascular health of women: a review by the Italian Society of Cardiology Working Group on 'gender cardiovascular diseases' 975
null 944
Metabolomic approach to foetal and neonatal heart 920
Contribution of metabolomics to the understanding of nafld and nash syndromes: A systematic review 904
Cardiopulmonary and endothelial effects of metformin treatment in an insulin resistant population 812
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin 797
The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy 786
Metabolomic correlates of coronary atherosclerosis, cardiovascular risk, both or neither. Results of the 2 × 2 phenotypic CAPIRE study 766
null 745
Early epirubicin-induced myocardail dysfunction revealed by serial tissue doppler echocardiography (TDI). Correlation with inflammatory and oxidative stress markers 743
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 735
Metabolomic Profiles on Antiblastic Cardiotoxicity: New Perspectives for Early Diagnosis and Cardioprotection 712
La Metabolomica: una nuova era in Cardiologia. Le nostre esperienze originali nei campi dell' insufficienza cardiaca, della cardiopatia ischemica e dell' ipertensione polmonare 707
Subclinical contractility impairment in HIV-infected patients: dependence on the class of antiretroviral drugs 682
A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics 646
Cardioprotective effect of Telmisartan in cancer patients treated with Epirubicin 641
Gender determinants of cardiovascular risk factors and diseases 630
Cardiac effects of L-thyroxine administration in borderline hypothyroidism 627
Cardiorespiratory Fitness, Preclinical Systolic and Dyastolic Dysfunctions and HRQoL in Men with Type 2 Diabetes 619
Early Strain Rate impairment during treatment with epirubicin is associated with high levels of reactive oxygen species 610
Cardiovascular modulation during vagus nerve stimulation therapy in patients with refractory epilepsy 599
Totale 199.353
Salva come PNG Salva come JPEG
Categoria #
all - tutte 259.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 259.499
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20227.462 0 0 467 814 717 670 456 511 947 845 1.006 1.029
2022/202313.092 1.267 2.022 1.775 1.157 1.140 1.093 566 849 819 765 1.039 600
2023/202414.413 724 547 614 968 1.426 2.452 2.357 919 973 935 1.243 1.255
2024/202544.484 7.462 8.569 5.317 16.410 1.493 2.395 1.659 143 321 202 220 293
2025/20268.611 433 399 908 635 674 778 1.337 868 653 796 440 690
2026/2027593 82 377 134 0 0 0 0 0 0 0 0 0
Totale 208.301